Research Article
Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy
Table 2
Serum XOD activity, uric acid, IMA, and other biomarkers of protein modifications in control subjects and type 2 diabetes mellitus patients with and without diabetic peripheral neuropathy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as mean values ± standard deviation. Differences between groups were tested by one-way ANOVA and post hoc Student’s -test. XOD: xanthine oxidase; IMA: ischemia-modified albumin; AGE: advanced glycation end products; AOPP: advanced protein oxidation products; RFU: relative fluorescence units. versus control group; versus non-DPN group. |